期刊文献+

Changes in plasma hydrogen sulfide and nitric oxide levels and their clinical significance in children with Kawasaki disease 被引量:9

Changes in plasma hydrogen sulfide and nitric oxide levels and their clinical significance in children with Kawasaki disease
原文传递
导出
摘要 Background Cardiac involvement is the most common complication of Kawasaki disease (KD); however, the underlying mechanisms are not understood. The present study was designed to investigate changes in plasma hydrogen sulfide (H2S) and nitric oxide (NO) levels in the acute and recovery stages of KD children and to examine their clinical significance. Methods Thirty-five KD patients and 32 healthy children were enrolled in the study. KD patients were divided into two subgroups: a non-cardiac involvement group and a cardiac involvement group. Plasma H2S levels were measured using the sulfur-sensitive electrode method and plasma NO levels and NO synthase activity were determined using the nitrate reductase method both before and after intravenous immune globulin (IVIG) therapy. Results Plasma H2S levels significantly decreased in KD patients during the acute phase of the disease and NO levels were significantly increased, compared with the control group (P 〈0.01). After treatment with IVIG, both plasma H2S and NO levels significantly increased (P 〈0.01). The plasma levels of H2S were significantly lower in the cardiac involvement group compared with the non-cardiac involvement group (P 〈0.05). Conclusion H2S and NO may play a role in the pathophysiological process of inflammation during the acute phase of KD. Endogenous H2S may exert protective effects with respect to cardiac complications in KD. Background Cardiac involvement is the most common complication of Kawasaki disease (KD); however, the underlying mechanisms are not understood. The present study was designed to investigate changes in plasma hydrogen sulfide (H2S) and nitric oxide (NO) levels in the acute and recovery stages of KD children and to examine their clinical significance. Methods Thirty-five KD patients and 32 healthy children were enrolled in the study. KD patients were divided into two subgroups: a non-cardiac involvement group and a cardiac involvement group. Plasma H2S levels were measured using the sulfur-sensitive electrode method and plasma NO levels and NO synthase activity were determined using the nitrate reductase method both before and after intravenous immune globulin (IVIG) therapy. Results Plasma H2S levels significantly decreased in KD patients during the acute phase of the disease and NO levels were significantly increased, compared with the control group (P 〈0.01). After treatment with IVIG, both plasma H2S and NO levels significantly increased (P 〈0.01). The plasma levels of H2S were significantly lower in the cardiac involvement group compared with the non-cardiac involvement group (P 〈0.05). Conclusion H2S and NO may play a role in the pathophysiological process of inflammation during the acute phase of KD. Endogenous H2S may exert protective effects with respect to cardiac complications in KD.
出处 《Chinese Medical Journal》 SCIE CAS CSCD 2011年第21期3445-3449,共5页 中华医学杂志(英文版)
关键词 hydrogen sulfide Kawasaki disease nitric oxide hydrogen sulfide Kawasaki disease nitric oxide
  • 相关文献

参考文献17

  • 1Mitchell JA,Ali F,Bailey L,Moreno L,Harrington LS.Role of nitric oxide and prostacyclin as vasoactive hormones released by the endothelium.Exp Physiol 2008; 93:141-147.
  • 2Du J,Hui Y,Cheung Y,Bin G,Jiang H,Chen X,et al.The possible role of hydrogen sulfide as a smooth muscle cell proliferation inhibitor in rat cultured cells.Heart Vessels 2004;19:75-80.
  • 3Bettowski J,Jamroz-Wi(s)niewska A,Tokarzewska D.Hydrogen sulfide and its modulation in arterial hypertension and atherosclerosis.Cardiovasc Hematol Agents Med Chem 2010; 8:173-186.
  • 4Qiao W,Chaoshu T,Hongfang J,Junbao D.Endogenous hydrogen sulfide is involved in the pathogenesis of atherosclerosis.Biochem Biophys Res Commun 2010; 396:182-186.
  • 5Wang XB,Jin HF,Tang CS,Du JB.Significance of endogenous sulphur-containing gases in the cardiovascular system.Clin Exp Pharmacol Physiol 2010; 37:745-752.
  • 6Newburger JW,Takahashi M,Gerber MA,Gewitz MH,Tani LY,Bums JC,et al.Diagnosis,treatment,and long-term management of Kawasaki disease:a statement for health professionals from the Committee on Rheumatic Fever,Endocarditis,and Kawasaki Disease,Council on Cardiovascular Disease in the Young,American Heart Association.Pediatrics 2004; 115:1708-1733.
  • 7Adewuya O,Irie Y,Bian K,Onigu-Otite E,Murad F.Mechanism of vasculitis and aneurysms in Kawasaki disease:role of nitric oxide.Nitric Oxide 2003; 8:15-25.
  • 8Li X,Jin H,Bin G,Wang L,Tang C,Du J.Endogenous hydrogen sulfide regulates pulmonary artery collagen remodeling in rats with high pulmonary blood flow.Exp Biol Med (Maywood) 2009; 234:504-512.
  • 9Fiorucci S.Hydrogen sulfide:from physiology to pharmacology.Infiamm Allergy Drug Targets 2011; 10:77-84.
  • 10Zanardo RC,Brancaleone V,Distrutti E,Fiorucci S,Cirino G,Wallace JL.Hydrogen sulfide is an endogenous modulator of leukocyte-mediated inflammation.FASEB J 2006; 20:2118-2120.

同被引文献31

引证文献9

二级引证文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部